EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation

Michel Abou Khalil iD, Christian M Massad iD, Eli Tsakiris iD, William Herbst, Maximilian Moersdorf iD, Mohammad Montaser Atasi iD, Yara Menassa, Alex El Darzi iD, Carlo El Khoury iD, Ghassan Bidaoui iD, Hadi Younes iD, Yishi Jia und 6 weitere

Journal of Cardiovascular Electrophysiology · 2026-11 · 37 (11) · 2740-2750

DOI: 10.1111/jce.70519 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 06.10.2026. Verfasst von Michel Abou Khalil und 17 weiteren Autor:innen. Beteiligte Einrichtung: Tulane Research Innovation for Arrhythmia Discovery, Tulane University School of Medicine, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Pulmonary Veins, Atrial Fibrillation, Catheter Ablation. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary vein isolation (PVI) is the standard ablation strategy for paroxysmal atrial fibrillation (PAF). Despite guideline recommendations favoring PVI alone in PAF, some operators routinely perform extra pulmonary vein ablation (PVI+) during initial procedures.

Objective

To determine frequency of PVI+ strategy for treatment of PAF in the real world and examine its impact on arrhythmic recurrence and progression compared to PVI alone.

Methods

Using the TriNetX research network, we identified adults with PAF who underwent catheter ablation between January 2020 and January 2024. Recurrence was defined as repeat ablation, cardioversion, or antiarrhythmic drug (AAD) use beyond a 3‐month blanking period. Progression to persistent AF and atypical atrial flutter were also assessed. Kaplan‐Meier analysis was performed with 3‐year follow‐up.

Results

Before matching, 5134 of 18,891 patients (27.2%) underwent PVI+. In the propensity matched analysis ( n = 5020 per group), recurrence was significantly higher in the PVI+ group (HR 1.28, 95% CI 1.16–1.42; p < 0.001). Repeat ablation, cardioversion and AAD use were more common with PVI+ (HR 1.99, 95% CI 1.60–2.46; p < 0.0001, HR 1.37, 95% CI 1.13–1.66; p = 0.001, and HR 1.41, 95% CI 1.05–1.87; p = 0.020, respectively). Progression to persistent AF was higher with PVI+ (HR 1.37, 95% CI 1.23–1.53, p < 0.001), as was atypical atrial flutter (HR 2.63, 95% CI 1.97–3.50; p < 0.0001).

Conclusion

Extra‐pulmonary vein ablation during first‐time PAF ablation remains common in real‐world practice but is associated with worse outcomes including repeat ablation, cardioversion, AAD use, atrial flutter, and progression to persistent AF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary VeinsAtrial FibrillationCatheter AblationHumansRecurrenceTime FactorsMaleFemaleAction PotentialsMiddle AgedRisk FactorsTreatment OutcomeHeart RateAgedRetrospective StudiesRisk AssessmentAnti-Arrhythmia AgentsDisease ProgressionDatabases, Factual

Stichwörter der Autor:innen

antiarrhythmic drugsarrhythmia recurrenceatrial fibrillationatrial fluttercatheter ablationpulmonary vein isolationreal‐world evidence

Substanzen

Anti-Arrhythmia Agents

Autor:innen und Institutionen

  • Tulane Research Innovation for Arrhythmia Discovery, Tulane University School of Medicine, New Orleans, Louisiana, USA.

ORCID-Profile: Michel Abou Khalil, Christian M Massad, Eli Tsakiris, Maximilian Moersdorf, Mohammad Montaser Atasi, Alex El Darzi, Carlo El Khoury, Ghassan Bidaoui, Hadi Younes, Amitabh Pandey, Han Feng, Nassir F Marrouche, Omar Kreidieh

Zitieren

APA

Khalil, M. A., Massad, C. M., Tsakiris, E., Herbst, W., Moersdorf, M., Atasi, M. M., Menassa, Y., Darzi, A. E., Khoury, C. E., Bidaoui, G., Younes, H., Jia, Y., Montiel, R., Pandey, A., Feng, H., Marashly, Q., Marrouche, N. F., & Kreidieh, O. (2026). Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 37(11), 2740-2750. https://doi.org/10.1111/jce.70519

Vancouver

Khalil MA, Massad CM, Tsakiris E, Herbst W, Moersdorf M, Atasi MM, et al. Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2026;37(11):2740-2750. doi:10.1111/jce.70519

BibTeX
@article{Khalil2026,
  author = {Khalil, Michel Abou and Massad, Christian M and Tsakiris, Eli and Herbst, William and Moersdorf, Maximilian and Atasi, Mohammad Montaser and Menassa, Yara and Darzi, Alex El and Khoury, Carlo El and Bidaoui, Ghassan and Younes, Hadi and Jia, Yishi and Montiel, Rodolfo and Pandey, Amitabh and Feng, Han and Marashly, Qussay and Marrouche, Nassir F and Kreidieh, Omar},
  title = {Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  volume = {37},
  number = {11},
  pages = {2740--2750},
  doi = {10.1111/jce.70519}
}
Kostenlos starten →